|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2004-10-8
|
|
pubmed:abstractText |
We report a case of early-onset acute Guillain-Barre syndrome associated with reactivation of Epstein-Barr virus (EBV) infection after nonmyeloablative stem cell transplantation (NST). Reactivation of EBV infection preceded disease onset, and the virus load increased concomitantly with disease progression (doubling time, 2.7 days). This case raises concern about the expanding scope of manifestations associated with reactivation of EBV infection after NST.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
pubmed-author:BitanMenachemM,
pubmed-author:MadorNurithN,
pubmed-author:OrReuvenR,
pubmed-author:ResnickIgor BIB,
pubmed-author:SalehNiveenN,
pubmed-author:SamuelSimchaS,
pubmed-author:SchechterEstherE,
pubmed-author:ShapiraMichael YMY,
pubmed-author:SlavinShimonS,
pubmed-author:WeinbergerKlaus MKM,
pubmed-author:WolfDana GDG
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1076-8
|
|
pubmed:meshHeading |
pubmed-meshheading:15472865-Antilymphocyte Serum,
pubmed-meshheading:15472865-Busulfan,
pubmed-meshheading:15472865-Epstein-Barr Virus Infections,
pubmed-meshheading:15472865-Guillain-Barre Syndrome,
pubmed-meshheading:15472865-Humans,
pubmed-meshheading:15472865-Male,
pubmed-meshheading:15472865-Middle Aged,
pubmed-meshheading:15472865-Samarium,
pubmed-meshheading:15472865-Stem Cell Transplantation,
pubmed-meshheading:15472865-Vidarabine,
pubmed-meshheading:15472865-Virus Activation
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation.
|
|
pubmed:affiliation |
Department of Bone Marrow Transplantation and Cancer Chemotherapy, Hadassah University Hospital, Jerusalem, Israel. mbitan@hadassah.org.il
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
